Knowledge of dental professionals and Dental students on bisphosphonates and bisphosphonate-associated osteonecrosis of the jaws
DOI:
https://doi.org/10.33448/rsd-v11i9.31553Keywords:
Bisphosphonates; Bisphosphonate-associated osteonecrosis of the jaw; Knowledge; Teaching; Dentistry.Abstract
Introduction and objective: the present study assessed the knowledge of dentists and dental students about bisphosphonates and bisphosphonate-associated osteonecrosis of the jaws (BAONJ). Methodology: a survey was applied to dentists and dental students during dental meetings in the city of Rio de Janeiro/RJ, Brazil. Results were descriptively and comparatively analyzed using the SPSS program. Results: the final sample (n=308) was composed mostly by young adults, females (n=233; 76%) and 52% (n=159) were dental students. Most participants (n=185; 60%) were derived from private dental schools. From the total, 79% (n=243) of the participants told they had some information about bisphosphonates, 68% (n=209) recognized BAONJ as a possible side effect of their use, and 84% (n=259) considered important to ask about bisphosphonates use during anamnesis. Participants with more access to information, derived from public dental schools and graduate dentists demonstrated a higher understanding about the indications for bisphosphonates use, their action mechanism, BAONJ as an adverse effect, risk factors associated with the drugs, oral risk factors and oral care measures important to BAONJ risk reduction. Conclusions: there are several knowledge gaps on bisphosphonates and BAONJ and understanding these difficulties is important for the establishment of strategies of diffusion of the information and changing teaching models in dental schools, dental meetings and extension activities.
References
Acharya, S., Patil, V., Ravindranath, V., Kudva, A. & Nikhil, K. (2022). Medication-related osteonecrosis of the jaw: knowledge and perceptions of medical professionals on the usage of bone modifying agents and dental referrals. J Med Life, 15 (3), 368-373.
Al-Eid, R, Alduwayan, T., Khuthaylah, M. B. & Al Shemali, M. (2020). Dentists' knowledge about medication-related osteonecrosis of the jaw and its management. Heliyon, 6 (7), e04321.
Al-Maweri, A. S., Alshammari, M. N., Alharbi, A. R., Bahein, A. A., Alhajj, M. N., Al-Shamiri, H. M., Alahmary, A. W. & Doumani, M. (2020). Knowledge and opinions of Saudi dentists regarding dental treatment of patients undergoing bisphosphonates. Eur J Dent, 14 (1), 144-151.
Alhussain, A., Peel, S., Dempster, L., Clokie, C. & Azarpazhooh, A. (2015). Knowledge, practices, and opinions of Ontario dentists when treating patients receiving bisphosphonates. J Oral Maxillofac Surg, 73 (6), 1095-1105.
Almousa, M. A., Alharbi, G. K., Alqahtani, A. S., Chachar, Y., Alkadi, L. & Aboalela, A. (2021). Dental practitioners' and students' knowledge of medication related osteonecrosis of the jaw (MRONJ). Saudi Pharm J, 29 (1), 96-103.
Alqhtani, N. R., Almalki, A. K., Zuhair, F. A., Alenazi, A. A., Nabhan, A. B. & Alqahtani, M. (2020). Knowledge, attitude, and management of general dentist toward medication-related osteonecrosis of the jaws. J Pharm Bioallied Sci, 12 (Suppl 1), S151-154.
Arnaud, M. P., Talibi, S. & Lejeune-Cairon, S. (2021). Knowledge and attitudes of French dentists on bone resorption inhibitors (bisphosphonates and denosumab): a cross-sectional study. J Stomatol Oral Maxillofac Surg, S2468-7855 (21), 00086-0.
Brown, J. E., Cook, R. J., Major, P., Lipton, A., Saad, F., Smith, M., Lee, K. A., Zheng, M., Hei, Y. J. & Coleman, R. E. (2005). Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. J Natl Cancer Inst, 97 (1), 59-69.
Bruckmoser, E., Palaoro, M., Latzko, L., Schnabl, D., Neururer, S. B. & Laimer, J. (2021). Choosing the right partner for medication related osteonecrosis of the jaw: what central European dentists know. Int J Environ Res Public Health, 18 (9), 4466.
Coleman, R. E. (2008). Risks and benefits of bisphosphonates. Br J Cancer, 98 (11), 1736-1740.
Dahlgren, M. & Larsson Wexell, C. (2020). Uncertainty managing patients treated with antiresorptive drugs: a cross-sectional study of attitudes and self-reported behavior among dentists in Sweden. Acta Odontol Scand, 78 (2), 109-117.
De Lima, P. B., Brasil, V. L. M., de Castro, J. F. L., de Moraes Ramos-Perez, F. M., Alves, F. A., dos Anjos Pontual, M. L. & Perez, D. E. C. (2015). Knowledge and attitudes of Brazilian dental students and dentists regarding bisphosphonate-related osteonecrosis of the jaw. Support Care Cancer, 23 (12), 3421-3426.
Dodson, T. B. (2015). The frequency of medication-related osteonecrosis of the jaw and its associated risk factors. Oral Maxillofac Surg Clin North Am, 27 (4), 509-516.
Escobedo, M., García-Consuegra, L., Junquera, S., Olay, S., Ascani, G. & Junquera, L. (2018). Medication-related osteonecrosis of the jaw: a survey of knowledge, atitudes, and practices among dentists in the principality of Asturias (Spain). J Stomatol Oral Maxillofac Surg, 119 (5), 395-400.
Escobedo, M. F., García-Consuegra, L., Gay, S., Álvarez, L., Olay, S., Ascani, G. & Junquera, L. (2017). Influence of the teaching program on the learning in knowledge and practice of osteonecrosis of the jaws produced by antireasorptives in dental students of the Principality of Asturias (Spain). J Clin Exp Dent, 9 (12), e1402-1407.
Fliefel, R., Tröltzsch, M., Kühnisch, J., Ehrenfeld, M. & Otto, S. (2015). Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. Int J Oral Maxillofac Surg, 44 (5), 568-585.
Franchi, S., Brucoli, M., Boffano, P., Dosio, C. & Benech. A. (2020). Medical students' knowledge of medication related osteonecrosis of the jaw. J Stomatol Oral Maxillofac Surg, 121 (4), 344-346.
Hristamyan-Cilev, M. A., Pechalova, P. P., Raycheva, R. D., Hristamyan, V. P., Kevorkyan, A. K. & Stoilova, Y. D. (2019). Bisphosphonate-associated osteonecrosis of the jaws: a survey of the level of knowledge of dentist about the risks of bisphosphonate therapy. Folia Med, 61 (2), 303-311.
Kim, J-W., Kwak, M. K., Han, J. J., Lee, S-T., Kim, H. Y., Kim, S. H., Jung, J., Lee, J. K., Lee, Y-K., Kwon, Y-D. & Kim, D-Y. (2021). Medication related osteonecrosis of the jaw: 2021 position statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons. J Bone Metab, 28 (4), 279-296.
López-Jornet, P., Camacho-Alonso, F., Molina-Miñano, F. & Gomez-Garcia, F. (2010). Bisphosphonate-associated osteonecrosis of the jaw. Knowledge and attitudes of dentists and dental students: a preliminary study. J Eval Clin Pract, 16 (5), 878-882.
Miranda-Silva, W., Montezuma, M. A., Benites, B. M., Bruno, J. S., Fonseca, F. P. & Fregnani, E. R. (2020). Current knowledge regarding medication-related osteonecrosis of the jaw among different health professionals. Support Care Cancer, 28 (11), 5397-5404.
Ozkan, E., Bereket, M. C. & Ozkan, N. (2021). Knowledge and attitude regarding bisphosphonates and related osteonecrosis among Turkish dentist: a cross sectional study. Niger J Clin Pract, 24 (10), 1485-1491.
Patil, V., Acharya, S., Vineetha, R. & Nikhil, K. (2020). Awareness about medication-related osteonecrosis of the jaw among dental professionals: a multicentre study. Oral Health Prev Dent, 18 (1), 505-509.
Rosella, D., Papi, P., Pompa, G., Capogreco, M., De Angelis, F. & Di Carlo, S. (2017). Dental students' knowledge of medication-related osteonecrosis of the jaw. Eur J Dent, 11 (4), 461-468.
Ruggiero, S. L., Dodson, T. B., Aghaloo, T., Carlson, E. R., Ward, B. B. & Kademani, D. (2022). American Association of Oral and Maxillofacial Surgeons' position paper on medication-related osteonecrosis of the jaws - 2022 update. J Oral Maxillofac Surg, 80 (5), 920-943.
Ruggiero, S. L., Dodson, T. B., Fantasia, J., Goodday, R., Aghaloo, T., Mehrotra, B. & O´Ryan, F. (2014). American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg, 72 (10), 1938-1956.
Saad, F., Brown, J. E., Van Poznak, C., Ibrahim, T., Stemmer, S. M., Stopeck, A. T., Diel, I. J., Takahashi, S., Shore, N., Henry, D. H., Barrios, C. H., Facon, T., Senecal, F., Fizaki, K., Zhou, L., Daniels, A., Carrière, P. & Dansey, R. (2012). Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol, 23 (5), 1341-1347.
Senturk, M. F., Cimen, E., Tuzuner Oncul, A. M. & Cambazoglu, M. (2016). Oncologists awareness about bisphosphonate related osteonecrosis of the jaws. J Pak Med Assoc, 66 (7), 880-883.
Tanna, N., Steel, C., Stagnell, S. & Bailey, E. (2017). Awareness of medication related osteonecrosis of the jaws (MRONJ) amongst general dental practitioners. Br Dent J, 222 (2), 121-125.
Vinitzky-Brener, I., Ibáñez-Mancera, N. G., Aguilar-Rojas, A. M. & Álvarez-Jardón, A. P. (2017). Knowledge of bisphosphonate-related osteonecrosis of the jaws among Mexican dentists. Med Oral Patol Oral Cir Bucal, 22 (1), e84-87.
Yoneda, T., Hagino, H., Sugimoto, T., Ohta, H., Takahashi, S., Soen, S., Taguchi, A., Nagata, T., Urade, M., Shibahara, T. & Toyosawa, S. (2017). Antiresorptive agent-related osteonecrosis of the jaw: position paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw. J Bone Miner Metab, 35 (1), 6-19.
Young, R. N. & Grynpas, M. D. (2018). Targeting therapeutics to bone by conjugation with bisphosphonates. Curr Opin Pharmacol, 40, 87-94.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Leonardo Paredes; Lúcio Souza Gonçalves; Águida Maria Menezes Aguiar Miranda; Juliana de Noronha Santos Netto; Danyel Elias da Cruz Perez; Fábio Ramoa Pires
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
